Mode
Text Size
Log in / Sign up

Cell-mediated immunity and mucosal responses characterize early infection in ruminants with Johne's diseaseUnderstanding Immune Responses and Vaccine Challenges in Ruminants with Johne Disease

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Note that early infection in Johne's disease involves cell-mediated responses and complex mucosal immunology.

This mini review explores the immunological landscape of Johne's disease in ruminants, specifically focusing on host immune responses to Mycobacterium avium subsp. paratuberculosis (MAP). The scope includes an analysis of mucosal immunology and the current hurdles in vaccine development.

The authors synthesize that infection is characterized by a predominantly cell-mediated immune response during early stages. Regarding vaccine efficacy, findings indicate partial, region-specific protection and the induction of mucosal immune responses. These results highlight the complexity of the host-pathogen interaction at mucosal surfaces.

Several limitations are noted, including poorly defined correlates of protection and significant knowledge gaps regarding the specific mechanisms underlying mucosal immunity to MAP. These gaps currently limit the ability to develop highly effective vaccines.

Identifying these research gaps is essential for advancing vaccine research for Johne's disease. Clinical application remains limited by the current lack of clear protective markers, but understanding these immune pathways is a necessary step toward developing more robust veterinary interventions.

Johne disease is a long-lasting illness in farm animals like sheep and goats. It is caused by a specific bacteria that attacks the digestive tract. Because it stays in the body for a long time, it is very hard for the animal's immune system to clear out completely.

Research shows that the body tries to fight the infection early on using cell-mediated immunity. This means the body sends specialized cells to the area of infection to try and stop the bacteria from spreading. However, these defenses are often not enough to stop the disease entirely in many cases.

Creating a vaccine is currently very difficult. While some vaccines have shown small amounts of protection in specific areas, they do not provide full immunity. Scientists are still trying to figure out exactly what triggers a strong enough response to keep animals healthy over time.

To make better vaccines, experts need to understand how the lining of the gut reacts to the bacteria. By filling these knowledge gaps, researchers hope to develop more effective ways to protect livestock and improve overall animal health.

What this means for you:
Better understanding of gut immunity is needed to overcome current hurdles in creating effective Johne disease vaccines.

Common questions

What is Johne's disease?

Johne's disease is a chronic bacterial infection in ruminants like cattle, sheep, and goats. It causes severe weight loss, diarrhea, and eventually death. The bacterium responsible is Mycobacterium avium subsp. paratuberculosis (MAP).

How effective are current vaccines for Johne's disease?

Current vaccines provide only partial protection. They work better in some regions than others. They can induce some immune response in the gut lining, but not enough to fully prevent infection or disease.

What are the main challenges in developing a better vaccine?

Scientists don't fully understand what a protective immune response looks like. The review highlights major knowledge gaps in how the gut's immune system responds to MAP. Without clear immune markers that predict protection, it's hard to design more effective vaccines.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJun 2026
View Original Abstract ↓
Johne’s disease, caused by Mycobacterium avium subsp. paratuberculosis (MAP), is a chronic enteric infection of ruminants characterized by persistence in intestinal macrophages following invasion through Peyer’s patches. Early studies established a predominantly cell-mediated immune response during early stages of infection, yet this fails to clear mucosal infection. Recent vaccine studies demonstrate partial, region-specific protection and induction of mucosal immune responses but also reveal marked differences in responses across intestinal regions. Correlates of protection are poorly defined and key knowledge gaps remain in defining the mechanisms underlying mucosal immunity to MAP in ruminants. In this mini review, we synthesize current knowledge of host immune responses to MAP and highlight research gaps from a mucosal immunology perspective that continue to impede vaccine development. Addressing these gaps is essential to advance vaccine research for Johne’s disease.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.